Skip to Main Content

Paper Details

Future of Rare Diseases Research 2017-2027: An IRDiRC Perspective.
Clin Transl Sci
129
2018
Rare Diseases
Author NameAffiliation
Christopher P AustinNational Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH)
Christine M CutilloNational Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH)
Ana RathInserm-US14
Ana RathInserm-US14
Ana RathInserm-US14
Ana RathInserm-US14
Daria Julkowska
Sharon F Terry
Sharon F Terry
Kym M BoycottChildren's Hospital of Eastern Ontario Research Institute, University of Ottawa
Gareth BaynamKing Edward Memorial Hospital
Gareth Baynam
Gareth BaynamKing Edward Memorial Hospital
Gareth Baynam
Petra KaufmannNational Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH)
Domenica TaruscioNational Centre for Rare Diseases, Istituto Superiore di Sanita
Hanns Lochm??llerInstitute of Genetic Medicine, Newcastle University
Makoto Suematsu
Ruxandra Draghia-Akli
Ruxandra Draghia-AkliMerck & Co. Inc.
Irene Norstedt
Hugh Dawkins
Hugh Dawkins
  • 1 - 23

Datasets

Release 1.2